How does MLCL's PB Ratio compare to its peers?

Insufficient data to calculate MLCL's Price-To-Book Ratio vs. peers for valuation analysis.

How does MLCL's PB Ratio compare vs other companies in the CA Pharmaceuticals Industry?

Insufficient data to calculate MLCL's Price-To-Book Ratio vs. industry for valuation analysis.

What is MLCL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MLCL's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MLCL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MLCL's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Molecule Holdings (CNSX:MLCL) - Stock Price, News & Analysis

MLCL Stock Overview

Engages in production and co-packing of cannabis-infused beverages in Canada. More details

MLCL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Negative shareholders equity

Earnings have declined by 20.4% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap (CA$489K)

+ 1 more risk

Molecule Holdings Inc. Competitors

Hempsana Holdings

CNSX:HMPS

CA$591.3k

SugarBud Craft Growers

TSXV:SUGR.H

CA$718.6k

West Island Brands

CNSX:WIB

CA$2.0m

Herbal Dispatch

CNSX:HERB

CA$4.5m

Price History & Performance

Summary of all time highs, changes and price drops for Molecule Holdings
Historical stock prices
Current Share Price	CA$0
52 Week High	CA$0.015
52 Week Low	CA$0.005
Beta	-0.78
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	n/a

Recent updates

Shareholder Returns

	MLCL	CA Pharmaceuticals	CA Market
7D	n/a	-6.9%	2.2%
1Y	n/a	-22.8%	23.4%

Return vs Industry: Insufficient data to determine how MLCL performed against the Canadian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how MLCL performed against the Canadian Market.

Price Volatility

Is MLCL's price volatile compared to industry and market?
MLCL volatility
MLCL Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	12.0%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: MLCL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MLCL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	David Reingold	molecule.ca

Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It also offers cannabis extracts, beverages, edibles, and topical products directly to provincial retailers. The company offers its beverage products under the PHRESH, KLÕN, EMBODY, and CANAJO brands.

Molecule Holdings Inc. Fundamentals Summary

How do Molecule Holdings's earnings and revenue compare to its market cap?
MLCL fundamental statistics
Market cap	CA$488.91k
Earnings (TTM)	-CA$3.45m
Revenue (TTM)	CA$1.78m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MLCL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLCL income statement (TTM)
Revenue	CA$1.78m
Cost of Revenue	CA$2.23m
Gross Profit	-CA$449.70k
Other Expenses	CA$3.01m
Earnings	-CA$3.45m

Last Reported Earnings

Jul 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.035
Gross Margin	-25.27%
Net Profit Margin	-194.18%
Debt/Equity Ratio	-102.3%

How did MLCL perform over the long term?

See historical performance and comparison

MLCL Stock Overview

Risk Analysis

Molecule Holdings Inc. Competitors

CNSX:HMPS

CA$591.3k

TSXV:SUGR.H

CA$718.6k

CNSX:WIB

CA$2.0m

CNSX:HERB

CA$4.5m

Price History & Performance

Recent News & Updates

Less than half of directors are independent

Molecule Holdings Inc. Announces Change of Chief Financial Officer

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.009 loss in 2Q 2022)

New major risk - Revenue and earnings growth

Less than half of directors are independent

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Recent updates

Less than half of directors are independent

Molecule Holdings Inc. Announces Change of Chief Financial Officer

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.009 loss in 2Q 2022)

New major risk - Revenue and earnings growth

Less than half of directors are independent

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Molecule Holdings Inc. Launches New Products

Molecule Holdings Inc. Announces Embody Launch in British Columbia

Molecule Holdings Inc. announced that it expects to receive CAD 3 million in funding

Molecule Holdings Inc. announced that it has received CAD 0.6 million in funding

Less than half of directors are independent

Molecule Holdings Inc. Announces New Skus Available for Purchase Now with OCS

Molecule Holdings Inc., Annual General Meeting, Apr 27, 2022

Molecule Holdings Inc. to Launch Seven New Products in the Ontario Cannabis Store for Spring and Summer

Molecule Holdings Inc. Announces Addition of its Newest Brand Embody

Molecule Holdings Inc. Announces its Newest Lineup of Products Under the Brand Name Canajo

Less than half of directors are independent

Molecule Holdings Inc. announced that it has received CAD 2.434 million in funding

Molecule Holdings Inc. announced that it expects to receive CAD 1.5 million in funding

Molecule Holdings Inc. Announces Availability of the First 5 of Its Beverages for Purchase Online

Molecule Holdings Inc. Launches Phresh Cannabis Beverages for Canadian Summer Beverage Season

Molecule Holdings Inc. announced that it has received CAD 1 million in funding

Molecule Receives Opening Pipeline Orders from Ontario Cannabis Store

Molecule Holdings Inc., Annual General Meeting, Apr 30, 2021

Molecule Holdings Inc. Completes Test Production Run Preceding Health Canada Sales Amendment Application and Inventory Accumulation

Molecule Holdings Inc. Completes Full-Scale Test of Cannabis Beverage Production in its Health Canada Licensed Facility and Submits NNCP for New House Brand "52 Saturdays"

Molecule Holdings Inc. Submits Notice of New Cannabis Product for New House Brand, KLON Beverages

Molecule Signs a Letter of Intent with la Société Québécoise du Cannabis (SQDC)

Molecule Holdings Inc. Signs Cannabis Supply Agreement with ABcann Medicinals Inc

Molecule Holdings Inc. Appoints Jeff Stoss as Chief Financial Officer

Molecule Signs Agreement with Hill Street Beverage Company Inc. to Produce Cannabis Infused Beverages

Molecule Holdings Inc. Signs Binding Term Sheet with Biolux Natural Health Inc

Molecule Inc. completed the acquisition of Everton Resources Inc. (TSXV:EVR) in a reverse merger transaction.

Molecule Holdings Inc. Receives Final Piece of Equipment for Producing Craft Cannabis Beverages

Shareholder Returns

Price Volatility

About the Company

Molecule Holdings Inc. Fundamentals Summary

0.0x

0.0x

Earnings & Revenue